ロード中...
Emerging therapies in mantle cell lymphoma
Mantle cell lymphoma (MCL) is a rare, B cell non-Hodgkin’s lymphoma with highly heterogeneous clinical presentation and aggressiveness. First-line treatment consists of intensive chemotherapy with autologous stem cell transplant for the fit, transplant eligible patients, or less intensive chemothera...
保存先:
| 出版年: | J Hematol Oncol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7302387/ https://ncbi.nlm.nih.gov/pubmed/32552760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-020-00914-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|